Description
R-Equol is the diasteromer of S-Equol. Although S-equol is a naturally occuring isoflavone metabolite in humans, R-equol is not. However, both of these diasteromers are biologically active.
| Product Unit Size | Cost | Quantity | Stock |
|---|
R-Equol is the diasteromer of S-Equol. Although S-equol is a naturally occuring isoflavone metabolite in humans, R-equol is not. However, both of these diasteromers are biologically active.
| Cas No. | 221054-79-1 |
|---|---|
| Purity | ≥98% |
| Formula | C15H14O3 |
| Formula Wt. | 242.27 |
| Chemical Name | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| IUPAC Name | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| Synonym | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Lephart E. Resveratrol, 4’ acetoxy resveratrol, R-equol, racemic equol or S-equol as cosmeceuticals to improve dermal health. Int J Mol Sci. 2017 Jun 3;18(6):1193. PMID: 28587197
Setchell K, Zhao X, Jha P, et al. The pharmacokinetic behavios of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers. Am J Clin Nutr. 2009 Oct;90(4):1029-1037. PMID: 19710188
EGFR, VEGFR inhibitor.
Triterpene glycoside found in Glycyrrhiza; 11β...
Protease substrate.
Dihydropyridine; L-type Ca2+ channel blocker.
Cysteine-ITC conjugate.
Antineoplastic immunomodulator.
Quinazoline; α1-adrenergic antagonist.
Steroid; glucocorticoid agonist.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Alkyl sulfonate; DNA alkylator.
Curcumin derivative.
Mast cell stabilizer; TRPV2 antagonist, PDGFR i...
Fungistatic
PORCN inhibitor.
Prevents MHC II antigen presentation.
Semi-synthetic vinca alkaloid from Catharanthus...
Curcumin derivative; DNMT1 and α-amylase inhib...
Coumarin; VKORC1 inhibitor.
Antihistamine with potential neuroprotective ac...
Smoothened agonist.